Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

13results about How to "Significant antidepressant effect" patented technology

Antidepressant benzenotriol compounds, methods of making and using the same

The application belongs to the technical field of medicines, and specifically discloses an anti-depression m-hydroxybenzoic acid compound and a preparation method and application thereof; the m-hydroxybenzoic acid compound Hyperioxides A-F provided by the application has not been reported; the six compounds have good anti-depression effects, and further research shows that the compounds Hyperioxide A, Hyperioxide D, Hyperioxide E and Hyperioxide F have significant protective effects on SH-SY5Y cells induced by corticosterone, and are superior to positive drugs fluoxetine and Luoyoutei, and can be used for developing drugs for treating depression.
Owner:CHINA JAPAN FRIENDSHIP HOSPITAL

Composite cannabidiol essential oil composition capable of resisting depression, soothing nerves and helping sleep and preparation method of composite cannabidiol essential oil composition

The invention provides a compound cannabidiol essential oil composition for resisting depression, soothing nerves and helping sleep and a preparation method thereof, and belongs to the technical field of depression resistance. The mosquito-repellent incense is prepared from the following raw materials in parts by weight: 5-7 parts of lavender, 3-5 parts of clove, 1-2 parts of folium artemisiae argyi, 4-6 parts of chamomile, 5-7 parts of bergamot, 3-5 parts of verbena blue, 2-4 parts of valeriana affinis, 0.01-0.02 part of a penetration enhancer and 0.05-0.1 part of cannabidiol. The prepared composite cannabidiol essential oil composition for resisting depression, soothing nerves and helping sleep is safe to use, is extracted from flowers and plants, and has very good effects on relieving human mood, relieving pressure and improving insomnia and has very good effects on depression and insomnia.
Owner:SHENZHEN HANENBAO BIOTECHNOLOGY CO LTD

Application of aryl olefine acid schisandra phenolic ester in preparation of medicine for treating depression and prepared anti-depression medicine

The invention provides an application of aryl olefine acid schisandra chinensis phenolic ester (O-dihydroxyphenyl) hernandezine and a derivative thereof in preparation of a medicine for treating depression and an anti-depression medicine prepared from the O-dihydroxyphenyl hernandezine and the derivative of the O-dihydroxyphenyl hernandezine and the derivative of the O-dihydroxyphenyl hernandezine. The application dosage is 0.01-30 mg of aryl olefine acid schisandra phenolic ester or the derivative thereof per kilogram of body weight, and the anti-depression effect can be achieved within 60 minutes after administration. After the medicine is administrated for 5 days, a remarkable anti-depression effect can be generated at a high dosage. A research result shows that in a mammal mouse tail suspension experiment, the aryl olefine acid schisandra phenolic ester or the derivative thereof has a rapid anti-depression effect and is more effective than a conventional anti-depression drug fluoxetine. According to the invention, a forced swimming experiment and a mouse tail suspension experiment are adopted as drug screening experiments, and meanwhile, an open field test is carried out on the mouse, so that the autonomous activity of the mouse is detected, and the interference of central excitation drugs is avoided. The anti-depression drug has the advantages of being remarkable in anti-depression effect, quick in effect taking, small in dosage, small in side effect and the like, and is expected to become a new anti-depression drug which is quick, efficient and novel in mechanism.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI +1

10-hydroxydecenoic acid glycosylated derivative as well as preparation method and application thereof

The invention belongs to the field of biological medicines, and particularly relates to a 10-hydroxydecenoic acid glycosylated derivative as well as a preparation method and application thereof. The invention accidentally finds that (1) the prepared glycosylated derivative is good in water solubility, the water solubility is far higher than that of a prototype component 10-hydroxydecenoic acid, the glycosylated derivative can be directly dissolved in water to be prepared into oral liquid or injection, and the glycosylated derivative is convenient to use and has a good anti-depression effect; (2) The described acetylated derivative is poorly soluble in water, but has higher fat solubility than the prototype component 10-hydroxydecenoic acid, and has higher anti-depression efficacy than the original substance 10-hydroxydecenoic acid. Compared with the existing rapid antidepressant drug ketamine and clinical first-line antidepressant fluoxetine, the glycosylated derivative prepared by the invention has a remarkable effect of improving behavioral indexes, and the antidepressant effect of the glycosylated derivative is close to that of ketamine and is remarkably superior to that of fluoxetine. Therefore, the compound provided by the invention provides a thought for preparing a rapid antidepressant drug.
Owner:CHINA PHARM UNIV

A pharmaceutical composition and its use in the manufacture of a medicament for the treatment of major depressive disorder

ActiveCN119700767Bsignificant antidepressant effectlower dose
The application discloses a kind of pharmaceutical composition and its purposes in preparation for treating major depressive disorder of drug. The pharmaceutical composition includes esketamine and yohimbine. The yohimbine in the pharmaceutical composition provided by the application can effectively promote the antidepressant effect of esketamine, significantly reduce the dosage of esketamine when it plays the antidepressant effect, prolong the duration of antidepressant effect, and a certain dosage of yohimbine can promote the antidepressant effect of less dosage of esketamine.
Owner:XUZHOU MEDICAL UNIVERSITY

Application of composition as synergist of depression treatment medicine

The invention discloses application of a composition as a synergist of a drug for treating depression, the composition is prepared from pyrola, loranthus parasiticus, pyrrosia lingua, oldenlandia diffusa and achyranthes bidentata, and the drug for treating depression is prepared from astragalus membranaceus, bighead atractylodes rhizome, poria cocos, codonopsis pilosula, radix aconiti lateralis preparata (black prepared common monkshood daughter root), dogwood, salvia miltiorrhiza and motherwort. A drug combination prepared from the composition and a depression treatment drug can significantly improve depression-like behaviors of depression mice, relieve interest deficiency symptoms and increase neurotransmitter content in brains of the depression mice. Further clinical tests find that the medicine combination has remarkable clinical effects on depression of various traditional Chinese medicine syndromes such as liver depression and qi stagnation, liver depression transforming into fire, liver depression and spleen deficiency, phlegm and qi stagnation, heart and spleen deficiency, kidney deficiency and liver depression and the like, shows a good anti-depression effect and has a wide application prospect.
Owner:GUANGZHOU BAIYUNSHAN MINGXING PHARM CO LTD

A method for extracting antidepression active euphausia superba oil by subcritical combined solvent extraction

The application discloses a method for extracting antidepression active Euphausia superba oil by adopting subcritical combination solvent, and belongs to the technical field of deep processing of Euphausia superba. The method is a three-stage gradient extraction method of "subcritical butane-acetone-ethanol", and realizes differential separation and enrichment of lipid components by using solvent polarity difference. The first-stage subcritical butane extraction is carried out under low temperature, closed and oxygen isolation conditions, and high-efficiency desolventizing is realized by using reduced pressure gasification, so that the heat-sensitive active ingredients are effectively reserved, and meanwhile, oxidation and metamorphosis of raw materials are avoided, thereby laying a foundation for preparation of subsequent high-quality extracts. The method successfully prepares three Euphausia superba oil products with significant component differences, and especially, the third-stage extract and the enzymatic modification product thereof exhibit excellent antidepression activity. The application realizes functional separation of Euphausia superba lipid components, and provides strong support for development of personalized and diversified antidepression products.
Owner:GUANGDONG LABORATORY OF SOUTHERN OCEAN SCIENCE AND ENGINEERING (GUANGZHOU) +1

Application of antrodia camphorata triterpenes in treatment of depression

The invention discloses an application of antrodia camphorata total triterpenes in treating depression. The antrodia camphorata total triterpenes are obtained by extracting antrodia camphorata sporocarp or mycelium. The antrodia camphorata total triterpenes are the main active substance in the antrodia camphorata sporocarp, and the content of the triterpenes in the antrodia camphorata is far higher than that of the ganoderma lucidum. The antrodia camphorata triterpenes in the invention can significantly improve depressive symptoms and restore neurotransmitter and inflammatory factor levels. In addition, the antrodia camphorata triterpene also has the effects of dispelling the effects of alcohol, protecting the liver, resisting hepatic fibrosis, tumor, fatigue, cancer, inflammation and virus, reducing blood pressure, regulating immunity, regulating intestinal flora and the like. The antrodia camphorata triterpene is wide in source, remarkable in effect, free of side effects and diversified in function, and has great development value and good application prospects in treating or relieving depression.
Owner:YANGZHOU UNIV

Traditional Chinese medicine composition with effects of improving sleep and resisting depression as well as application, preparation and preparation method of traditional Chinese medicine composition

The invention discloses a traditional Chinese medicine composition with effects of improving sleep and resisting depression, and application, a preparation and a preparation method thereof, and relates to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition with the sleep improving and depression resisting effects is prepared from the following raw materials in parts by weight: 5 to 100 parts of semen ziziphi spinosae, 5 to 100 parts of semen persicae, 5 to 100 parts of fructus gardeniae, 5 to 100 parts of semen sojae praeparatum, 10 to 200 parts of concha ostreae, 1 to 20 parts of arillus longan and 1 to 10 parts of gamma-aminobutyric acid. The traditional Chinese medicine composition with the effects of improving sleep and resisting depression, which is provided by the technical scheme of the invention, can be used for remarkably shortening the sleep time of rats with insomnia and improving the content of 5-hydroxytryptamine, dopamine and melatonin in brain tissues, and is used for improving the symptoms such as difficulty in falling asleep, insomnia, easy waking, dreaminess and anxiety; the traditional Chinese medicine composition helps patients to improve sleep quality and accompanying depressive symptoms, and is small in side effect and stable in curative effect.
Owner:SOUTHERN MARINE SCIENCE & ENGINEERING GUANGDONG LABORATORY (ZHANJIANG)

Tea bag capable of soothing liver-qi stagnation and preparation method thereof

PendingCN119280313Asignificant antidepressant effectimprove depressive symptomsPowder deliveryNervous disorderHypericum perforatumHypericum myrianthum
The invention discloses a tea bag capable of soothing liver-qi stagnation, and relates to the related technical field of tea products, and the tea bag comprises the following components (by mass): 10-20 parts of hypericum perforatum, 10-20 parts of spina date seed, 8-12 parts of longan aril, 8-12 parts of wine-processed cornel, and 8-12 parts of jujube. The invention also discloses a preparation method of the tea bag for soothing liver-qi stagnation. The preparation method comprises the following steps: drying, crushing, sterilizing, quantitatively mixing and packaging. The beverage disclosed by the invention has the effects of soothing liver-qi stagnation and tranquilizing and allaying excitement, effectively relieves the depressive mood of a patient, has a curative effect similar to that of fluoxetine, is better in safety, and is prepared into an instant tea bag product through scientific compatibility of traditional Chinese medicinal materials with the effects of soothing liver-qi stagnation and combining a modern tea making process; effective components of the traditional Chinese medicinal materials are reserved, the tea is convenient to carry and drink, and the health requirements of modern people in fast-paced life are met.
Owner:XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV

Natural plant essential oil for calming the mind and promoting sleep, preparation method and sleeping patch

The invention relates to the technical field of natural plant essential oils for calming the mind and promoting sleep, and in particular to natural plant essential oils for calming the mind and promoting sleep, a preparation method and a sleeping patch. The natural plant essential oils are prepared from the following components by weight: 20-25 parts of linalool; 15-20 parts of citral; 10-15 parts of alpha-pinene; 8-12 parts of carvacrol; 6-10 parts of (R)-(-)-carvone; 5-9 parts of nerolidol; 4-8 parts of geraniol; 5-10 parts of beta-cyclodextrin; 3-7 parts of soybean lecithin; 1-3 parts of vitamin E; 2-6 parts of spiny jujube kernel oil and 1-4 parts of bergamot oil; linalool and alpha-pinene achieve comprehensive regulation of the sleep-wake cycle, significantly improve the levels of GABA and 5-HT in the brain, shorten the sleep latency and prolong the sleep time; the spiny jujube kernel oil has the effects of sedation, sleep-promoting and anti-anxiety; and the bergamot oil has the effects of sedation, anti-depression and mood improvement.
Owner:LOOBI GUANGZHOU HEALTH IND CO LTD +1

Medical use of an aporphine alkaloid

The application discloses a use of an aporphine alkaloid shown in formula III in preparation of an antidepressant, wherein R1 and R2 are independently selected from alkoxy and methylenedioxy, R3 and R4 are independently selected from H, OH, alkoxy and methylenedioxy, but R3 and R4 cannot be H at the same time or R1 and R2 are both selected from methoxy, and R3 cannot be OH and R4 cannot be H. Pharmacological experiments show that the aporphine alkaloid shown in formula III has better antidepressant effect, higher response rate and faster effect than fluoxetine.
Owner:CHINA PHARM UNIV

Folium cortex eucommiae pharmaceutical composition for improving depression as well as preparation method and application of folium cortex eucommiae pharmaceutical composition

The invention discloses a folium cortex eucommiae pharmaceutical composition for improving depression as well as a preparation method and application thereof, and relates to the technical field of medicines. The preparation method comprises the following steps: performing liquid nitrogen low-temperature crushing on eucommia ulmoides leaves, performing enzymolysis fermentation on cellulase and pectinase, performing secondary enzymolysis on beta-glucosidase, performing ultrasonic ethanol extraction on filter residues obtained by enzymolysis, performing acetic fermentation, combining secondary enzymolysis liquid and acetic fermentation liquid, and concentrating to obtain eucommia ulmoides leaf extracting liquid; the extracting solution has the effects of improving depression, resisting inflammation and inhibiting HPA axis excitation, can be used as a pharmaceutical composition or a conventional additive for preparing medicines for preparing the medicines for improving depression, resisting inflammation and inhibiting HPA axis excitation, can be prepared into various dosage forms, including but not limited to tablets, capsules, pills, oral solutions, injections and the like, and can be used for preparing medicines for improving depression, resisting inflammation and inhibiting HPA axis excitation. The application value is realized in efficient utilization of the folium cortex eucommiae and depression improvement treatment.
Owner:XIHUA UNIV